Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

YTHDF1 promotes hepatocellular carcinoma progression via activating PI3K/AKT/mTOR signaling pathway and inducing epithelial-mesenchymal transition
Xiangyuan Luo, Mengdie Cao, Fan Gao, et al.
Experimental Hematology and Oncology (2021) Vol. 10, Iss. 1
Open Access | Times Cited: 74

Showing 1-25 of 74 citing articles:

Role of m6A writers, erasers and readers in cancer
Zhen Fang, Wentong Mei, Chang Qu, et al.
Experimental Hematology and Oncology (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 148
Biological impact and therapeutic perspective of targeting PI3K/Akt signaling in hepatocellular carcinoma: Promises and Challenges
Mahshid Deldar Abad Paskeh, Fatemeh Ghadyani, Mehrdad Hashemi, et al.
Pharmacological Research (2022) Vol. 187, pp. 106553-106553
Open Access | Times Cited: 85
The structure and function of YTHDF epitranscriptomic m6A readers
Vilbert Sikorski, Simona Selberg, Maciej Łałowski, et al.
Trends in Pharmacological Sciences (2023) Vol. 44, Iss. 6, pp. 335-353
Open Access | Times Cited: 55
Focal adhesion kinase: from biological functions to therapeutic strategies
Ximin Tan, Yuheng Yan, Bin Song, et al.
Experimental Hematology and Oncology (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 54
N6-methyladenosine reader YTHDF family in biological processes: Structures, roles, and mechanisms
Lin Chen, Yang Gao, Simiao Xu, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 50
m6A binding protein YTHDF2 in cancer
Xiaohong Chen, Xiangxiang Zhou, Xin Wang
Experimental Hematology and Oncology (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 63
HGF/c-Met pathway facilitates the perineural invasion of pancreatic cancer by activating the mTOR/NGF axis
Tao Qin, Ying Xiao, Weikun Qian, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 4
Open Access | Times Cited: 39
The emerging importance role of m6A modification in liver disease
Sheng Wang, Songsen Gao, Wufei Ye, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 162, pp. 114669-114669
Open Access | Times Cited: 30
ALKBH5 prevents hepatocellular carcinoma progression by post-transcriptional inhibition of PAQR4 in an m6A dependent manner
Weijian Wang, Qibo Huang, Zhibin Liao, et al.
Experimental Hematology and Oncology (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 26
Signaling pathways in liver cancer: pathogenesis and targeted therapy
Yangtao Xue, Yeling Ruan, Yali Wang, et al.
Molecular Biomedicine (2024) Vol. 5, Iss. 1
Open Access | Times Cited: 13
RNA modification-mediated mRNA translation regulation in liver cancer: mechanisms and clinical perspectives
Shuibin Lin, Ming Kuang
Nature Reviews Gastroenterology & Hepatology (2024) Vol. 21, Iss. 4, pp. 267-281
Closed Access | Times Cited: 10
The Role of m6A RNA Methylation in Cancer: Implication for Nature Products Anti-Cancer Research
Na Song, Kai Cui, Ke Zhang, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 33
METTL14-mediated N6-methyladenosine modification of ITGB4 mRNA inhibits metastasis of clear cell renal cell carcinoma
Zhuonan Liu, Tianshui Sun, Chiyuan Piao, et al.
Cell Communication and Signaling (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 31
The potential role of m6A reader YTHDF1 as diagnostic biomarker and the signaling pathways in tumorigenesis and metastasis in pan-cancer
Yanan Zhu, Jing Li, Hang Yang, et al.
Cell Death Discovery (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 18
RNA m6A methylation regulators in liver cancer
Qiaoping Xu, Ning Ren, Lanqi Ren, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 8
Mechanisms and clinical landscape of N6-methyladenosine (m6A) RNA modification in gastrointestinal tract cancers
Danhua Zhu, Kunkai Su, Xiaoxi Ouyang, et al.
Molecular and Cellular Biochemistry (2024) Vol. 479, Iss. 7, pp. 1553-1570
Open Access | Times Cited: 6
Photosensitive and dual-targeted chromium nanoparticle delivering small interfering RNA YTHDF1 for molecular-targeted immunotherapy in liver cancer
Shang Chen, Yan He, Xin Huang, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 6
N6-Methyladenosine RNA-Binding Protein YTHDF1 in Gastrointestinal Cancers: Function, Molecular Mechanism and Clinical Implication
Danyu Chen, Henley Cheung, Harry Cheuk-Hay Lau, et al.
Cancers (2022) Vol. 14, Iss. 14, pp. 3489-3489
Open Access | Times Cited: 23
Insights into the Role of Oxidative Stress in Hepatocellular Carcinoma Development
Yuanyuan Li, Yang Yu, Lei Yang, et al.
Frontiers in Bioscience-Landmark (2023) Vol. 28, Iss. 11, pp. 286-286
Open Access | Times Cited: 13
HHLA2 promotes hepatoma cell proliferation, migration, and invasion via SPP1/PI3K/AKT signaling pathway
Junqi Wang, Kehu Yang, Xin Yang, et al.
Molecular Carcinogenesis (2024) Vol. 63, Iss. 7, pp. 1275-1287
Closed Access | Times Cited: 5
The role of RNA modification in hepatocellular carcinoma
Qiang Feng, Dongxu Wang, Tianyi Xue, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 20
Roles of RNA Methylations in Cancer Progression, Autophagy, and Anticancer Drug Resistance
Hyein Jo, Kyeonghee Shim, Dooil Jeoung
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 4225-4225
Open Access | Times Cited: 11
New horizons for the role of RNA N6-methyladenosine modification in hepatocellular carcinoma
Yujia Li, Yangling Qiu, Meng-ran Li, et al.
Acta Pharmacologica Sinica (2024) Vol. 45, Iss. 6, pp. 1130-1141
Closed Access | Times Cited: 4
Targeting RNA modifications with pharmacological agents: New frontiers in cancer therapy
Angel Guan, Justin Wong
Cancer Medicine (2024) Vol. 13, Iss. 7
Open Access | Times Cited: 4
YTHDF1 promotes gallbladder cancer progression via post‐transcriptional regulation of the m6A/UHRF1 axis
Jiemin Chen, Xuesong Bai, Wen-Qin Zhang, et al.
Journal of Cellular and Molecular Medicine (2024) Vol. 28, Iss. 9
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top